89 reports of this reaction
1.4% of all COLESTIPOL HYDROCHLORIDE reports
#16 most reported adverse reaction
PRODUCT PHYSICAL ISSUE is the #16 most commonly reported adverse reaction for COLESTIPOL HYDROCHLORIDE, manufactured by Pharmacia & Upjohn Company LLC. There are 89 FDA adverse event reports linking COLESTIPOL HYDROCHLORIDE to PRODUCT PHYSICAL ISSUE. This represents approximately 1.4% of all 6,329 adverse event reports for this drug.
Patients taking COLESTIPOL HYDROCHLORIDE who experience product physical issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT PHYSICAL ISSUE is a less commonly reported adverse event for COLESTIPOL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to product physical issue, the following adverse reactions have been reported for COLESTIPOL HYDROCHLORIDE:
The following drugs have also been linked to product physical issue in FDA adverse event reports:
PRODUCT PHYSICAL ISSUE has been reported as an adverse event in 89 FDA reports for COLESTIPOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT PHYSICAL ISSUE accounts for approximately 1.4% of all adverse event reports for COLESTIPOL HYDROCHLORIDE, making it a notable side effect.
If you experience product physical issue while taking COLESTIPOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.